Operating Lease, Right-of-Use Asset of Y-mAbs Therapeutics, Inc. from 31 Mar 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Y-mAbs Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $3,109,000, a 145% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $3,109,000 +$1,838,000 +145% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $601,000 -$578,000 -49% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $817,000 -$595,000 -42% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $1,075,000 -$518,000 -33% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $1,271,000 +$93,000 +7.9% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $1,179,000 -$190,000 -14% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,412,000 -$327,000 -19% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $1,593,000 -$576,000 -27% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,178,000 -$1,203,000 -51% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $1,369,000 -$1,786,000 -57% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $1,739,000 -$2,103,000 -55% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $2,169,000 -$633,000 -23% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $2,381,000 -$1,017,000 -30% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $3,155,000 -$824,000 -21% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $3,842,000 -$727,000 -16% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $2,802,000 -$2,321,000 -45% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $3,398,000 +$1,640,000 +93% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $3,979,000 +$2,114,000 +113% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $4,569,000 +$2,580,000 +130% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $5,123,000 +$3,037,000 +146% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,758,000 -$458,000 -21% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $1,865,000 -$455,000 -20% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $1,989,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $2,086,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $2,216,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $2,320,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.